Compare QSI & AGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | QSI | AGD |
|---|---|---|
| Founded | 2013 | 2006 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 273.7M | 288.1M |
| IPO Year | N/A | N/A |
| Metric | QSI | AGD |
|---|---|---|
| Price | $1.30 | $11.39 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $2.88 | N/A |
| AVG Volume (30 Days) | ★ 4.5M | 61.2K |
| Earning Date | 11-05-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.13% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,177,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $159.68 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 40.20 | N/A |
| 52 Week Low | $0.95 | $8.20 |
| 52 Week High | $5.77 | $9.78 |
| Indicator | QSI | AGD |
|---|---|---|
| Relative Strength Index (RSI) | 39.26 | 43.94 |
| Support Level | $1.26 | $11.14 |
| Resistance Level | $1.54 | $11.92 |
| Average True Range (ATR) | 0.09 | 0.17 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 16.46 | 26.76 |
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.
Aberdeen Global Dynamic Dividend Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current dividend income, more than 50% of which qualifies for the reduced federal income tax rate, as created by the Jobs and Growth Tax Relief Reconciliation Act of 2003. The fund also focuses on the long-term growth of capital as a secondary investment objective. The fund's portfolio holdings are in information technology, financials, health care, and consumer discretionary sectors among others.